Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jan 25 | PSTX Poseida Therapeutics | Common Stock | Dispose U | No | No | 0 | 78,600 | 0.00 | 0 | |
8 Jan 25 | PSTX Poseida Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.81 | 27,350 | 76.85 k | 0 |
8 Jan 25 | PSTX Poseida Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.47 | 27,350 | 67.55 k | 0 |
8 Jan 25 | PSTX Poseida Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.01 | 57,000 | 114.57 k | 0 |
20 Jun 24 | ACRV Acrivon Therapeutics, Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 6.52 | 20,275 | 132.19 k | 20,275 |
17 Jun 24 | PSTX Poseida Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 19,650 | 0.00 | 78,600 |
17 Jun 24 | PSTX Poseida Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.81 | 27,350 | 76.85 k | 27,350 |
6 Jun 24 | PMVP PMV Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 1.65 | 67,500 | 111.38 k | 67,500 |
23 Jan 24 | MRTX Mirati Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 20,425 | 0.00 | 0 |
23 Jan 24 | MRTX Mirati Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 94,057 | 0.00 | 20,425 |